We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 10,000 results
  1. Real-world experience with VMAT2 inhibitors in Tourette syndrome

    Objectives

    We aimed to review our “real-world” experience with the vesicular monoamine transporter 2 (VMAT2) inhibitors tetrabenazine,...

    Karim Makhoul, Joseph Jankovic in Journal of Neurology
    Article 11 June 2023
  2. Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease

    Acute graft versus host disease (aGVHD) is a complication of allogeneic hematopoietic stem cell transplant (HCT) and is associated with significant...

    Alistair Murray, Swe Mar Linn, ... Dennis Dong Hwan Kim in Bone Marrow Transplantation
    Article 24 February 2024
  3. Personalized venlafaxine dose prediction using artificial intelligence technology: a retrospective analysis based on real-world data

    Background

    Venlafaxine dose regimens vary considerably between individuals, requiring personalized dosing.

    Aim

    This study aimed to identify...

    Yimeng Liu, Ze Yu, ... Chunhua Zhou in International Journal of Clinical Pharmacy
    Article 11 May 2024
  4. Diabetes Therapy Podcast: Real-World Data for Glucose Sensing Technologies in Type 1 Diabetes

    For people living with type 1 diabetes (T1D), home glucose monitoring has evolved from occasional qualitative urine tests to frequently sampled...

    Nick Oliver in Diabetes Therapy
    Article Open access 25 November 2022
  5. Real-world practice patterns of eplerenone use for central serous chorioretinopathy

    Purpose

    To report eplerenone use by retina specialists worldwide for central serous chorioretinopathy (CSCR).

    Methods

    A self-reporting questionnaire...

    Ramesh Venkatesh, Vishma Prabhu, ... Jay Chhablani in International Journal of Retina and Vitreous
    Article Open access 02 October 2023
  6. Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data

    Objectives

    Nivolumab is approved as adjuvant therapy for resected stage III/IV melanoma based on the phase 3 CheckMate 238 trial. This analysis...

    Justin C. Moser, Shailender Bhatia, ... Jeffrey Weber in Cancer Immunology, Immunotherapy
    Article Open access 07 May 2024
  7. Andexanet Alfa: What We Have Learned from Clinical Trials and Real-World Data

    Andexanet alfa is a specific reversal agent for factor Xa inhibitors with immediate reversal of their anticoagulant effect. Andexanet alfa is...

    Senta Frol, Janja Pretnar Oblak, ... Pawel Kermer in CNS Drugs
    Article 23 February 2024
  8. Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?

    Treatment guidelines for colorectal cancer (CRC) are primarily based on the results of randomized clinical trials (RCTs), the gold standard...

    Sietske C. M. W. van Nassau, Guus M. Bol, ... Jeroen W. G. Derksen in Current Treatment Options in Oncology
    Article Open access 17 February 2024
  9. UroPredict: Machine learning model on real-world data for prediction of kidney cancer recurrence (UroCCR-120)

    Renal cell carcinoma (RCC) is most often diagnosed at a localized stage, where surgery is the standard of care. Existing prognostic scores provide...

    Gaëlle Margue, Loïc Ferrer, ... Jean-Christophe Bernhard in npj Precision Oncology
    Article Open access 23 February 2024
  10. Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action

    Presently, Gulf Cooperation Council countries are lagging in the generation of real-world data and use of real-world evidence for patient-centered...

    Mohamed Nasr Mahmoud Hassan Farghaly, Ibrahim Sulaiman Mas’oud Al Ghaithi, ... Nancy Syed Awad Abdallah in Drugs - Real World Outcomes
    Article Open access 17 November 2022
  11. Exact-matching algorithms using administrative health claims database equivalence factors for real-world data analysis based on the target trial emulation framework

    Real-world data have become increasingly important in medical science and healthcare. A new, effective, and practically feasible statistical design...

    Yuichi Nishioka, Emiri Morita, ... Tomoaki Imamura in Health Services and Outcomes Research Methodology
    Article Open access 02 February 2024
  12. Real-World-Daten zu Proteasominhibitor

    Marie-Thérèse Weitzl in InFo Hämatologie + Onkologie
    Article 14 December 2023
  13. A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients

    Purpose

    Men with localized or locally advanced prostate cancer (LPC/LAPC) are at risk of progression after radiotherapy (RT) or radical prostatectomy...

    Stephen J. Freedland, Sandhya Nair, ... Neeraj Agarwal in World Journal of Urology
    Article Open access 15 November 2023
  14. The impact of menopause on antidepressant response: an explorative analysis from a real-world study

    This study endeavors to deepen our understanding of the subject matter by exploring, within a real-world sample, the impact of menopausal status on...

    Matteo Carminati, Valentina Fazio, ... Raffaella Zanardi in Archives of Women's Mental Health
    Article 08 April 2024
  15. Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based study

    Background

    Despite recent advancements in migraine treatment, some patients continue to endure significant disease burden. Due to the controlled...

    Charles Argoff, Steven P. Herzog, ... Fawad A. Khan in The Journal of Headache and Pain
    Article Open access 25 April 2024
  16. Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study

    Introduction

    The objective was to characterize real-world outcomes of drug–drug interactions (DDIs) between antiretrovirals (ARVs) and other drugs,...

    Juan Ambrosioni, Natalia Anahí Díaz, ... Jose Molto in Infectious Diseases and Therapy
    Article Open access 19 February 2024
  17. Real-World Evidence on Levetiracetam-Induced Hypokalemia: An Active Comparator Cohort Study

    Background

    Levetiracetam is an anti-seizure medication (ASM) with an established safety profile. However, a potential safety signal of hypokalemia...

    Ohoud Almadani, Raseel Alroba, ... Adel A. Alrwisan in Drugs - Real World Outcomes
    Article Open access 03 June 2024
  18. Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study

    Introduction

    Oral semaglutide improves cardiovascular risk factors in people with type 2 diabetes (T2D) in clinical trials, though real-world evidence...

    David M. Williams, Barbara-Alex Alberts, ... Thinzar Min in Diabetes Therapy
    Article Open access 09 May 2024
  19. Evaluation of reporting quality of cohort studies using real-world data based on RECORD: systematic review

    Objective

    Real-world data (RWD) and real-world evidence (RWE) have been paid more and more attention in recent years. We aimed to evaluate the...

    Ran Zhao, Wen Zhang, ... Bin Wang in BMC Medical Research Methodology
    Article Open access 29 June 2023
  20. Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study

    Background

    Parkinson’s disease is now one of the fastest-growing neurodegenerative disorders in the developed world, with an increasing prevalence and...

    K. Ray Chaudhuri, Jean-Philippe Azulay, ... Pablo Martinez-Martin in Drugs - Real World Outcomes
    Article Open access 09 January 2024
Did you find what you were looking for? Share feedback.